Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018

Abstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological inform...

Full description

Bibliographic Details
Main Authors: Zhen Wang, Bin Zhao, Minghui An, Wei Song, Xue Dong, Xin Li, Lu Wang, Lin Wang, Wen Tian, Haibo Ding, Xiaoxu Han
Format: Article
Language:English
Published: BMC 2021-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-021-06312-3
id doaj-76db6b4eb595495eb18e8e295ce3908b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Zhen Wang
Bin Zhao
Minghui An
Wei Song
Xue Dong
Xin Li
Lu Wang
Lin Wang
Wen Tian
Haibo Ding
Xiaoxu Han
spellingShingle Zhen Wang
Bin Zhao
Minghui An
Wei Song
Xue Dong
Xin Li
Lu Wang
Lin Wang
Wen Tian
Haibo Ding
Xiaoxu Han
Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
BMC Infectious Diseases
HIV-1
Pre-exposure prophylaxis
Transmitted drug resistance
author_facet Zhen Wang
Bin Zhao
Minghui An
Wei Song
Xue Dong
Xin Li
Lu Wang
Lin Wang
Wen Tian
Haibo Ding
Xiaoxu Han
author_sort Zhen Wang
title Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
title_short Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
title_full Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
title_fullStr Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
title_full_unstemmed Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018
title_sort transmitted drug resistance to tenofovir/emtricitabine among persons with newly diagnosed hiv infection in shenyang city, northeast china from 2016 to 2018
publisher BMC
series BMC Infectious Diseases
issn 1471-2334
publishDate 2021-07-01
description Abstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological information of all newly diagnosed HIV-1 infected residents in Shenyang city from 2016 to 2018 were anonymously collected from the local HIV epidemic database. HIV-1 pol sequences were amplified from RNA in cryopreserved plasma samples and sequenced directly. Viral subtypes were inferred with phylogenetic analysis and drug resistance mutations (DRMs) were determined according to the Stanford HIVdb algorithm. Recent HIV infection was determined with HIV Limiting Antigen avidity electro immunoassay. Results A total of 2176 sequences (92.4%, 2176/2354) were obtained; 70.9% (1536/2167) were CRF01_AE, followed by CRF07_BC (18.0%, 391/2167), subtype B (4.7%, 102/2167), other subtypes (2.6%, 56/2167), and unique recombinant forms (3.8%, 82/2167). The prevalence of TDR was 4.9% (107/2167), among which, only 0.6% (13/2167) was resistance to TDF/FTC. Most of these subjects had CRF01_AE strains (76.9%, 10/13), were unmarried (76.9%, 10/13), infected through homosexual contact (92.3%, 12/13), and over 30 years old (median age: 33). The TDF/FTC DRMs included K65R (8/13), M184I/V (5/13), and Y115F (2/13). Recent HIV infection accounted for only 23.1% (3/13). Most cases were sporadic in the phylogenetic tree, except two CRF01_AE sequences with K65R (Bootstrap value: 99%). Conclusions The prevalence of TDR to TDF/FTC is low among newly diagnosed HIV-infected cases in Shenyang, suggesting that TDR may have little impact on the protective effect of the ongoing CROPrEP project in Shenyang city.
topic HIV-1
Pre-exposure prophylaxis
Transmitted drug resistance
url https://doi.org/10.1186/s12879-021-06312-3
work_keys_str_mv AT zhenwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT binzhao transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT minghuian transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT weisong transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT xuedong transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT xinli transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT luwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT linwang transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT wentian transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT haiboding transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
AT xiaoxuhan transmitteddrugresistancetotenofoviremtricitabineamongpersonswithnewlydiagnosedhivinfectioninshenyangcitynortheastchinafrom2016to2018
_version_ 1721308577612693504
spelling doaj-76db6b4eb595495eb18e8e295ce3908b2021-07-11T11:51:48ZengBMCBMC Infectious Diseases1471-23342021-07-012111610.1186/s12879-021-06312-3Transmitted drug resistance to Tenofovir/Emtricitabine among persons with newly diagnosed HIV infection in Shenyang city, Northeast China from 2016 to 2018Zhen Wang0Bin Zhao1Minghui An2Wei Song3Xue Dong4Xin Li5Lu Wang6Lin Wang7Wen Tian8Haibo Ding9Xiaoxu Han10National Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityDepartment of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)Department of Food Safety and Nutrition, Shenyang Center for Health Service and Administrative Law Enforcement (Shenyang Center for Disease Control and Prevention)National Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityNational Clinical Research Center for Laboratory Medicine, NHC Key Laboratory of AIDS Immunology (China Medical University), The First Affiliated Hospital of China Medical UniversityAbstract Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Methods Demographic and epidemiological information of all newly diagnosed HIV-1 infected residents in Shenyang city from 2016 to 2018 were anonymously collected from the local HIV epidemic database. HIV-1 pol sequences were amplified from RNA in cryopreserved plasma samples and sequenced directly. Viral subtypes were inferred with phylogenetic analysis and drug resistance mutations (DRMs) were determined according to the Stanford HIVdb algorithm. Recent HIV infection was determined with HIV Limiting Antigen avidity electro immunoassay. Results A total of 2176 sequences (92.4%, 2176/2354) were obtained; 70.9% (1536/2167) were CRF01_AE, followed by CRF07_BC (18.0%, 391/2167), subtype B (4.7%, 102/2167), other subtypes (2.6%, 56/2167), and unique recombinant forms (3.8%, 82/2167). The prevalence of TDR was 4.9% (107/2167), among which, only 0.6% (13/2167) was resistance to TDF/FTC. Most of these subjects had CRF01_AE strains (76.9%, 10/13), were unmarried (76.9%, 10/13), infected through homosexual contact (92.3%, 12/13), and over 30 years old (median age: 33). The TDF/FTC DRMs included K65R (8/13), M184I/V (5/13), and Y115F (2/13). Recent HIV infection accounted for only 23.1% (3/13). Most cases were sporadic in the phylogenetic tree, except two CRF01_AE sequences with K65R (Bootstrap value: 99%). Conclusions The prevalence of TDR to TDF/FTC is low among newly diagnosed HIV-infected cases in Shenyang, suggesting that TDR may have little impact on the protective effect of the ongoing CROPrEP project in Shenyang city.https://doi.org/10.1186/s12879-021-06312-3HIV-1Pre-exposure prophylaxisTransmitted drug resistance